发明公开
- 专利标题： USE OF NKp46 FOR PREVENTING DIABETES
- 专利标题（中）： NKp46的用于预防1型糖尿病患者使用
-
申请号： EP10714095.6申请日： 2010-03-18
-
公开(公告)号： EP2408468A2公开(公告)日： 2012-01-25
- 发明人: MANDELBOIM, Ofer , PORGADOR, Angel , NAPARSTEK, Yaakov , GUR, Chamutal
- 申请人： Yissum Research Development Company of the Hebrew University of Jerusalem , Hadasit Medical Research Services And Development Ltd. , Ben-Gurion University Of The Negev Research And Development Authority
- 申请人地址： Hi-Tech Park, Edmond J. Safra Campus Givat Ram PO Box 39135 97390 Jerusalem IL
- 专利权人： Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services And Development Ltd.,Ben-Gurion University Of The Negev Research And Development Authority
- 当前专利权人： Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services And Development Ltd.,Ben-Gurion University Of The Negev Research And Development Authority
- 当前专利权人地址： Hi-Tech Park, Edmond J. Safra Campus Givat Ram PO Box 39135 97390 Jerusalem IL
- 代理机构： Becker Kurig Straus
- 优先权： US202629 20090319; US259340 20091109
- 国际公布： WO2010106542 20100923
- 主分类号： A61K38/17
- IPC分类号： A61K38/17
摘要：
The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes.
公开/授权文献
- EP2408468B1 USE OF NKp46 FOR PREVENTING TYPE 1 DIABETES 公开/授权日：2014-04-30
信息查询
IPC分类:
